 |
 |
|
|
|
|
Title: |
WO9525545A1:
THE USE OF DIMETICONE AS A TRANSPORT AND CARRIER SYSTEM AND/OR DRUG DELIVERY SYSTEM[French]
[ Derwent Title ]

|
Country:
Kind: |
WO World Intellectual Property Organization (WIPO)
A1 INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT i

|
| |
Inventor: |
SCHMIDT, Alfred;
UPMEYER, Hans-Jürgen;

|
Assignee: |
SCHMIDT, Alfred
UPMEYER, Hans-Jürgen
News, Profiles, Stocks and More about this company

|
Published / Filed: |
1995-09-28
/ 1995-03-15

|
Application Number: |
WO1995EP0000973

|
IPC Code: |
Advanced:
A61K 31/80;
A61K 47/34;
IPC-7:
A61K 47/34;

|
ECLA Code: |
A61K31/80; A61K47/34;

|
Priority Number: |

|
Abstract: |
The invention relates to dimethylpolysiloxane (dimeticone) to be used as a transport and carrier system and/or a drug delivery system for pharmaceutical drugs. Moreover, the invention relates to pharmaceutical compositions containing dimethylpolysiloxane as a transport and carrier system and/or as a drug delivery system in conbination with an active ingredient.
[French]

|
INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report

|
Designated Country: |
AM AT AU BB BE BF BG BJ BR BY CA CF CG CH CI CM CN CZ DE DK ES FI FR GA GB GE GN GR HU IE IT JP KE KG KP KR KZ LK LT LU LV MC MD MG ML MN MR MW NE NL NO NZ PL PT RO RU SD SE SI SK SN SZ TD TG TJ TT UA UG US UZ VN

|
Family: |
Show 39 known family members

|
First Claim:
Show all claims |
CLAIMS

|
Description
Expand description |
+ The Use of Dimeticone as a Transport and Carrier System and/or Drug Delivery System
+ TECHNICAL FIELD OF THE INVENTION
The invention relates to dimethylpolysiloxane (dimeticone) to be used as a transport and carrier system and/or a drug delivery system for pharmaceutical drugs for instance for the treatment of gastro-intestinal diseases. Moreover, the invention relates to pharmaceutical compositions containing dimethylpolysiloxane as a transport and carrier system and/or as a drug delivery system in combination with an active ingredient and methods related thereto.
+ BACKGROUND OF THE INVENTION
In order to avoid dose-related side effects, the galenics of a pharmaceutical composition should be such that only the dose of the active ingredient necessary to elicit the desired therapeutic effect needs to be administered.
+ SUMMARY OF THE INVENTION
The present invention provides a carrier that lends itself for use in particular galenic pharmaceutical forms for oral, rectal and intraoperative applications which release and/or fix the active ingredient continuously at the very site where it is to produce its effect or is absorbed.

|